-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Akanda (NASDAQ:AKAN) shares increased by 55.1% to $2.11 during Monday's pre-market session. The market value of their outstanding shares is at $3.5 million.
  • Alpha Tau Medical (NASDAQ:DRTS) stock rose 14.16% to $15.28. The market value of their outstanding shares is at $1.2 billion.
  • Health Catalyst (NASDAQ:HCAT) shares rose 13.24% to $1.71. The company's market cap stands at $113.6 million.
  • iTonic Holdings (NASDAQ:ITOC) stock increased by 12.12% to $2.22. The company's market cap stands at $14.4 million.
  • Quantum Cyber (NASDAQ:QUCY) shares moved upwards by 10.58% to $0.7. The company's market cap stands at $55.2 million. As per the news, the Q3 earnings report came out 2 days ago.
  • Lexeo Therapeutics (NASDAQ:LXEO) shares rose 10.45% to $3.17. The market value of their outstanding shares is at $235.5 million. As per the news, the Q3 earnings report came out today.

Losers

  • Helus Pharma (NASDAQ:HELP) shares decreased by 41.4% to $5.2 during Monday's pre-market session. The company's market cap stands at $648.1 million.
  • Microbot Medical (NASDAQ:MBOT) shares fell 28.99% to $0.69. The company's market cap stands at $65.7 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock decreased by 17.43% to $11.68. The market value of their outstanding shares is at $11.2 billion.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock fell 16.79% to $0.62. The company's market cap stands at $6.7 million.
  • Oragenics (AMEX:OGEN) shares decreased by 12.94% to $0.17. As per the news, the Q3 earnings report came out 2 days ago.
  • VolitionRX (AMEX:VNRX) stock decreased by 12.14% to $0.2. The company's market cap stands at $8.2 million. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending